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Background-—Acute complete occlusion of a coronary artery results in progressive ischemia, moving from the endocardium to the
epicardium (ie, wavefront). Dependent on time to reperfusion and collateral ﬂow, myocardial infarction (MI) will manifest, with
transmural MI portending poor prognosis. Late gadolinium enhancement cardiac magnetic resonance imaging can detect MI
with high diagnostic accuracy. Primary percutaneous coronary intervention is the preferred reperfusion strategy in patients with
ST-segment–elevation MI with <12 hours of symptom onset. We sought to visualize time-dependent necrosis in a population with
ST-segment–elevation MI by using late gadolinium enhancement cardiac magnetic resonance imaging (STEMI-SCAR project).
Methods and Results-—ST-segment–elevation MI patients with single-vessel disease, complete occlusion with TIMI
(Thrombolysis in Myocardial Infarction) score 0, absence of collateral ﬂow (Rentrop score 0), and symptom onset
<12 hours were consecutively enrolled. Using late gadolinium enhancement cardiac magnetic resonance imaging, the area at
risk and infarct size, myocardial salvage index, transmurality index, and transmurality grade (0–50%, 51–75%, 76–100%) were
determined. In total, 164 patients (aged 5411 years, 80% male) were included. A receiver operating characteristic curve
(area under the curve: 0.81) indicating transmural necrosis revealed the best diagnostic cutoff for a symptom-to-balloon time
of 121 minutes: patients with >121 minutes demonstrated increased infarct size, transmurality index, and transmurality
grade (all P<0.01) and decreased myocardial salvage index (P<0.001) versus patients with symptom-to-balloon times
≤121 minutes.
Conclusions-—In MI with no residual antegrade and no collateral ﬂow, immediate reperfusion is vital. A symptom-to-balloon time of
>121 minutes causes a high grade of transmural necrosis. In this pure ST-segment–elevation MI population, time to reperfusion to
salvage myocardium was less than suggested by current guidelines. ( J Am Heart Assoc. 2019;8:e012429. DOI: 10.1161/JAHA.
119.012429.)
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I schemic heart disease is the most common cause of deathworldwide.1 Despite major advances in both interventional
medical treatment/secondary prevention, mortality and
morbidity in patients with ST-segment–elevation myocardial
infarction (STEMI) remain substantial. Mortality is affected by
various factors including Killip class, local emergency logis-
tics, number of diseased coronary vessels, left ventricular (LV)
ejection fraction, and time to treatment.1 In cases of acute
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and complete coronary occlusion, besides area at risk (AAR),
protecting collateral ﬂow, and ischemic preconditioning, time
to reperfusion is the most important factor in the treatment of
STEMI patients. The wavefront concept of myocardial infarc-
tion (MI) states that myocardial necrosis is a time-dependent
ischemic process beginning from the endocardial layers and
moving up to the epicardium without essential lateral
extension2: A prolonged occlusion of the infarct-related artery
(IRA) will result in a high amount of myocardial necrosis and a
low amount of myocardial salvage. To limit myocardial
necrosis of the myocardium supplied by the IRA, the AAR,
blood ﬂow to the IRA has to be restored as soon as possible.3
Without protecting collateral ﬂow, sustained ischemia will
result in progressive transmural expansion of the myocardial
necrosis with the loss of myocardial salvage, portending
adverse prognosis.4–6 Thus, current guidelines recommend
primary percutaneous coronary intervention (PCI) as the
preferred reperfusion strategy in patients with STEMI within
12 hours of symptom onset, provided it can be performed
within 120 minutes from STEMI diagnosis (the time at which
the ECG of a patient with ischemic symptoms is interpreted as
presenting ST-segment elevation).1 However, despite major
advances in treatment and emergency medical care, a
substantial number of STEMI patients have transmural
infarction with adverse prognosis.7–9
Late gadolinium enhancement cardiac magnetic resonance
imaging (LGE-CMR) can determine ischemic scar with high
diagnostic accuracy compared with histology.10–12
By visualizing the ischemic wavefront process, the AAR,
infarct size (IS), and myocardial salvage are determined.11,13,14
Most CMR studies assessing the extent of MI in STEMI patients
are performed in patients with a symptom-to-balloon time of
>180 minutes.15 Furthermore, most studies also included
initial TIMI (Thrombolysis in Myocardial Infarction) antegrade
ﬂow ≥1 and patients with visible retrograde collateral ﬂow
(Rentrop grade ≥1).15 However, both of the latter conditions
mitigate the time-dependent progress of the ischemic wave-
front after total occlusion of a coronary artery.
We sought to investigate the time-dependent ischemic
wavefront process in a “pure” STEMI population lacking the
mentioned limitations by using a dedicated LGE-CMR protocol
in STEMI patients with the following characteristics: (1) single-
vessel disease only, (2) complete absence of antegrade ﬂow
(TIMI 0), (3) complete absence of visible retrograde collateral
ﬂow (Rentrop grade 0), and (4) presentation within 12 hours
of symptom onset.
Methods
Because of the sensitive nature of the data collected for this
study, requests to access the data set from qualiﬁed
researchers trained in human subject conﬁdentiality protocols
may be sent to the corresponding author.
Patient Population
Patients admitted with ﬁrst-time STEMI, no preinfarction
angina, and no prior cardiac history treated with primary PCI
at one of the 4 institutions (Stuttgart and T€ubingen, Germany;
Innsbruck, Austria; Bern, Switzerland) were eligible for study
participation if they had STEMI according to the European
Society of Cardiology/American College of Cardiology com-
mittee redeﬁnition16 and had onset of symptoms <12 hours.
Patients with (1) initial antegrade ﬂow of TIMI >0, (2)
retrograde collateral ﬂow of Rentrop >0, (3) multivessel
n=164
final population
n=27
• patient declined
• contraindication for CMR
• claustrophobia
• silent MI remote myocardium
• poor image quality
n=374
STEMI patients with single 
vessel disease and no 
history of CAD screened
n=191
STEMI w TIMI 0
n=183
- TIMI ≥1
- Rentrop ≥1
- symptom-to-balloon time >12h
Figure 1. Flowchart demonstrating the study population. CAD
indicates coronary arterial disease; CMR, cardiac magnetic
resonance; MI, myocardial infarction; STEMI, ST-segment–
elevation myocardial infarction; TIMI, Thrombolysis in Myocar-
dial Infarction.
Clinical Perspective
What Is New?
• In patients with ﬁrst-time acute ST-segment–elevation
myocardial infarction presenting with complete occlusion
of the culprit coronary artery and no coronary collaterals,
cardiac magnetic resonance imaging visualized time-depen-
dent transmural infarction with a cutoff of 121 minutes,
which seems much lower than reported for viable
myocardium.
What Are the Clinical Implications?
• This study highlights the therapeutic priority of reducing
ischemic times of patients presenting with ST-segment–
elevation myocardial infarction during emergency care
because in this pure ST-segment–elevation myocardial
infarction population, time to reperfusion to salvage
myocardium was less than suggested by current guidelines.
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disease (presence of >50% stenosis in >1 large epicardial
coronary artery according to coronary angiography during
primary PCI), (4) contraindications for CMR, (5) presence of
silent MI in remote myocardium, or (6) poor CMR image
quality were excluded (Figure 1). At each participating site,
the respective institutional review board approved the
Table 1. Baseline Characteristics
Entire Group ≤121 min >121 min
P Value(n=164) (n=64) (n=100)
Age, y 53.710.8 53.810.0 53.511.3 0.70
Sex (female) 33 (20) 16 (25) 17 (17) 0.22
Symptom-to-balloon, min 133 (103–196) 95 (77–110) 180 (137–249) <0.001*
CAD risk factors
Diabetes mellitus 17 (10) 5 (8) 12 (12) 0.48
Hypertension 74 (45) 33 (52) 41 (41) 0.31
Smoking† 48 (29) 14 (22) 34 (34) 0.11
Hyperlipidemia 70 (43) 34 (53) 36 (36) 0.04*
Family history of CVD 64 (39) 28 (44) 36 (36) 0.33
BMI, kg/m2 274.5 27.23.8 26.84.9 0.40
Hemodynamics
Systolic BP, mm Hg 13026 13027 13026 0.79
Diastolic BP, mm Hg 8116 8316 8016 0.13
Medication
Statins 28 (17) 9 (14) 19 (19) 0.52
b-Blockers 33 (20) 14 (22) 19 (19) 0.69
Aspirin 28 (17) 10 (16) 18 (18) 0.83
Clopidogrel 7 (4) 4 (6) 3 (3) 0.43
ARB 31 (19) 10 (16) 21 (21) 0.42
Biomarkers
CK 2668 (1431–4950) 2210 (1227–3509) 2912 (1606–5467) 0.02*
Coronary angiography
LAD 100 (61) 34 (53) 66 (66) 0.10
RCA 39 (24) 20 (31) 19 (19) 0.09
RCX 25 (15) 10 (16) 15 (15) 1.0
DES 144 (88) 54 (84) 90 (90) 0.33
Number of stents 1.30.6 1.30.6 1.30.6 0.85
Femoral approach 139 (85) 54 (84) 85 (85) 0.98
TIMI 1 after PCI 1 (1)  1 (1) 
TIMI 2 after PCI 14 (9) 5 (8) 9 (9) 1.0
TIMI 3 after PCI 149 (91) 59 (92) 90 (90) 0.78
MBG 0–1 23 (14) 10 (16) 13 (13) 0.65
MBG 2 49 (30) 20 (31) 29 (29) 0.86
MBG 3 92 (56) 34 (53) 58 (58) 0.63
Values are n (%), meanSD, or median (interquartile range). ARB indicates angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; CK,
creatine kinase; CVD, cardiovascular disease; DES, drug-eluting stent; LAD, left anterior descending; MBG, myocardial blush grade; PCI, percutaneous coronary intervention; RCA, right
coronary artery; RCX, right circumﬂex artery; TIMI, Thrombolysis in Myocardial Infarction
*Statistically signiﬁcant P-values (P<0.05).
†Current smokers.
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research protocol, and informed consent was obtained from
the participants. Since analyses were performed in STEMI
patients, visualizing myocardial scar by CMR, the project was
called STEMI-SCAR.
Primary PCI and Angiographic Analysis
Primary PCI was performed by experienced interventional
cardiologists. Pre- and post-PCI coronary angiographies were
performed, with the same projections permitting ofﬂine
evaluation of (1) TIMI ﬂow before and after PCI (range: 0–3),
(2) the Rentrop collateral grade (range: 0–3), and (3) the
myocardial blush grade (range: 0–3) at the ﬁnal angiogram by
2 independent interventional cardiologists (S.G., T.S.). Symp-
tom-to-balloon times (ie, time from onset of symptoms to
ﬁrst balloon inﬂation) were precisely reported for each
patient.
CMR Protocol
ECG-gated CMR was performed in breath hold using a 1.5-T
Magnetom Symphony, Magnetom Sonata, Magnetom Avanto,
or Magnetom Aera (Siemens Healthcare) in line with Society
for Cardiovascular Magnetic Resonance recommendations.12
Both cine and LGE short-axis CMR images were prescribed
every 10 mm (slice thickness: 6 mm) from base to apex. Cine
CMR was performed using a steady-state free-precession
sequence. LGE images were acquired on average 10 minutes
after contrast administration, using segmented inversion
recovery gradient echo constantly adjusting inversion time.
The contrast dose (gadodiamide, gadopentetate dimeglumine,
or gadobutrol) was 0.15 mmol/kg.
CMR Analysis
Image postprocessing was performed using dedicated soft-
ware (Argus [Siemens] and Mass [Medis], respectively). Cine
and contrast images were evaluated by experienced observers
(A.M., S.B., A.S., S.G.), as described elsewhere,17 and any
differences were resolved by consensus. In brief, endocardial
and epicardial borders were outlined on the short-axis cine
images. Volumes and LV ejection fractions were derived by
summation of epicardial and endocardial contours. LV mass
was calculated by subtracting endocardial from epicardial
volume at end-diastole and multiplying by 1.05 g/cm3. AAR
was drawn in LGE images indicating MI, as previously
described.11 AAR, IS, and microvascular obstruction (MVO)
were assessed using the Mass analysis software, and the
results were expressed as percentage of myocardial LV mass.
LGE was deﬁned of an image intensity level ≥2 SD above the
mean of remote myocardium.18 MVO was deﬁned as a
persisting area of hypoenhancement within regions of LGE.19
Furthermore, myocardial salvage index (MSI), equal to
(AARIS)/AAR9100, and transmurality index (100MSI)
were derived. In addition, infarct transmurality was graded
visually by quarters: <25%, 25% to 50%, 51% to 75%, and 76%
to 100% indicating transmural infarction.8,20 Analyses were
made blinded to clinical and angiographic parameters.
Statistical Analysis
Absolute numbers and percentages were computed to
describe the patient population. Categorical variables were
expressed as counts and percentages. Continuous variables
were expressed as meanSD or median (interquartile range),
as appropriate. Variables were tested for normal distribution
applying the D’Agostino–Pearson normality test. Comparisons
between groups were made using the Student t test for
normally distributed variables and the Mann-Whitney U test
for nonnormal distribution. Dichotomous variables were
compared using the Fisher exact test. P<0.05 (2-tailed) was
considered signiﬁcant. The Youden index was used to depict
the optimal cutoff value from the receiver operating charac-
teristic curve. Statistical analyses were performed using
GraphPad software or SPSS 22.0 (IBM Corp).
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Figure 2. Transmurality index and myocardial salvage index:
time-dependent parameters. A, Transmurality index increased,
with longer symptom-to-balloon time (minutes) mirroring the
ischemic wavefront. B, In contrast, the myocardial salvage index
decreased, with longer symptom-to-balloon time (minutes)
indicating progressive loss of myocardial salvage.
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Results
Patient Characteristics
Of the 374 screened patients, 164 were included in the ﬁnal
study cohort (Figure 1). Patients were aged 53.710.8 years
and predominantly male (80%); median symptom-to-balloon
time was 133 minutes (Table 1). The left anterior descending
artery was the most frequent IRA. TIMI 3 ﬂow after PCI was
achieved in >90% of patients.
CMR Characteristics
CMR was performed after a median of 4 days after STEMI. LV
ejection fraction was moderately reduced (5010%). Patients
demonstrated a low MSI (32.418.2) and, consequently, a
high transmurality index (67.618.2), which increased further
by prolonged symptom-to-balloon time (Figure 2). Among the
12 patients (7%) demonstrating a transmurality grade <50%, 3
patients (2%) showed no myocardial scar at all. Among those,
the mean symptom-to-balloon time was 5615 minutes,
whereas the mean symptom-to-balloon time for all 12 patients
demonstrating a transmurality grade <50% was 7729 min-
utes. Conversely, the majority of patients (n=137; 84%)
showed a high transmurality grade (76–100%) for the AAR.
Moreover, 64% of the patients demonstrated MVO, indicating
severe myocardial injury (Table 2).
Symptom-to-Balloon Time Cutoff for Imminent
Transmural Myocardial Necrosis
The receiver operating characteristic curve (area under the
curve: 0.81) indicating transmural myocardial necrosis
revealed the best diagnostic cutoff with a symptom-to-balloon
time of 121 minutes (Figure 3).
Dichotomous interpretation identiﬁed 64 patients with
a symptom-to-balloon time of ≤121 minutes (median: 95
minutes) and 100with a symptom-to-balloon time of>121 min-
utes (median 180 minutes; P<0.001). Beside the symptom-to-
Table 2. CMR characteristics
Entire Group ≤121 min >121 min
P Value(n=164) (n=64) (n=100)
Days to CMR 4 (2–6) 4 (2–5) 4 (2–8) 0.82
LVEF, % 5010 5110 4910 0.24
LVEDV, mL 15948 15745 16051 0.56
LVESV, mL 8439 7934 8842 0.15
LVSV, mL 7821 8021 7720 0.50
LV mass, g 130.731.8 130.135.5 131.930.2 0.75
AAR mass, g 48.425.8 44.627.8 50.825.1 0.10
Area at risk, % 36.917.7 34.019.4 38.416.7 0.17
Infarct mass, g 33.022.0 27.123.2 37.120.5 0.001*
Infarct size, % 26.016.0 20.816.9 29.214.7 0.003*
MSI, % 32.418.2 39.420.0 27.714.0 <0.001*
Transmurality index, % 67.618.2 60.620.0 72.314.0 <0.001*
Transmurality
0–50% 12 (7) 12 (19)  
51–75% 15 (9) 11 (17) 4 (4) 0.01*
76–100% 137 (84) 41 (64) 96 (96) <0.001*
MVO
Patients 105 (64) 34 (53) 71 (71) 0.03*
Mass, g 3.96.2 3.46.5 4.36.0 0.04*
% LV mass 3.24.5 2.84.7 3.44.4 0.09
% Infarct 9.210.9 9.112.8 9.39.5 0.20
Values are n (%), meanSD, or median (interquartile range). AAR indicates area at risk; CMR, cardiac magnetic resonance; LV, left ventricular; LVEDV, left ventricular end-diastolic volume;
LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; MSI, myocardial salvage index; MVO, microvascular obstruction.
*Statistically signiﬁcant P-values (P<0.05).
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balloon time, hyperlipidemia, and the serum creatine kinase
level (P=0.02), both groups showed similar baseline character-
istics (Table 1). However, CMR in patients with a symptom-to-
balloon time >121 minutes revealed a larger infarct mass and
IS, a higher grade of transmural infarction (ie, a higher
transmurality index), and a lower MSI compared with patients
with a symptom-to-balloon time ≤121 minutes (all P≤0.01;
Table 2). Consequently, in patients with a symptom-to-balloon
time >121 minutes, no patient showed a transmurality grade of
<50% compared with 12 (19%) patients in the group with a
symptom-to-balloon time of ≤121 minutes (Figure 4). The
relationship between symptom-to-balloon time and the occur-
rence of transmural necrosis is illustrated in Figure 5. Plausibly,
MVO was more frequent in patients with a symptom-to-balloon
time >121 minutes (P=0.03; Figure 6).
Discussion
This study is the ﬁrst to evaluate the time-dependent progress
of myocardial necrosis in a relatively pure model of STEMI in
patients with acute total occlusion of the IRA with completely
abolished antegrade ﬂow (TIMI 0) and without mitigation by
visible retrograde collateral ﬂow (Rentrop 0). Current guidelines
recommend primary PCI as the preferred reperfusion strategy
in STEMI patients within 12 hours of symptom onset (class 1
indication), and an absolute time from STEMI diagnosis to
mechanical reperfusion within 120 minutes.1 However, in our
more strictly deﬁned STEMI cohort, a symptom-to-balloon time
>121 minutes caused a high grade of transmural infarction
(and low MSI), underscoring the paramount importance of the
symptom-to-balloon time in the wavefront of myocardial
ischemia in patients not protected by a certain extent of
residual myocardial blood ﬂow from ante- or retrograde.
Patient Characteristics
Consistent with previous ﬁndings from STEMI registries,
patients were relatively young and predominantly male1,21;
median symptom-to-balloon time was 133 minutes, which
was much shorter than in other STEMI trials.15 TIMI 3 after
PCI could be achieved in >90% of the patients, similar to
previous STEMI studies.22
CMR Characteristics
LV ejection fraction was moderately reduced (5010%), in
line with previous data.23,24 Overall, patients demonstrated
low MSI (3218%) and a consistently high transmurality index
(6818%), which proceeds at sustained occlusion (longer
symptom-to-balloon time; Figure 2). Time dependency of
transmurality is further illustrated in the small subset of
patients with <50% transmurality: Of these, mean symptom-
to-balloon time increased from 5615 minutes in the 3
patients (2%) with no necrosis to 7729 minutes for all 12
patients (7%), demonstrating a degree of transmurality <50%.
In this relatively pure model of STEMI, these remarkably short
time intervals underscore the need for urgent restoration of
ﬂow in the IRA to prevent transmural wavefront expansion.
However, even in this patient cohort with relatively short
symptom-to-balloon times, the vast majority (n=137; 84%)
had a high transmurality grade (76–100%). Consequently, the
current recommendation of reperfusion in STEMI patients
presenting within 12 hours of symptom onset and 120 min-
utes from the STEMI diagnosis to primary PCI 1 may apply
only to a mixed all-comers STEMI population with partly
residual antegrade- and retrograde collateral ﬂow slowing the
ischemic wavefront to a certain extent.
Symptom-to-Balloon Time of 121 Minutes: The
Cutoff for Imminent Transmural Necrosis
Receiver operating characteristic curve analysis (area under
the curve: 0.81) indicating transmural myocardial necrosis
revealed the best diagnostic cutoff for a symptom-to-balloon
time of 121 minutes (Figure 3). CMR revealed larger infarct
mass and IS, higher grade of transmural infarction, and
increased transmurality index and lower MSI in the subgroup
with a symptom-to-balloon time >121 minutes versus
patients with a symptom-to-balloon time ≤121 minutes (all
P≤0.01; Table 2). Although previous studies support the
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Figure 3. ROC curve: cutoff of 121 minutes. ROC curve (AUC:
0.81; 95% CI, 0.73–0.90; P<0.0001) indicating transmural
myocardial necrosis revealed the best diagnostic cutoff for a
symptom-to-balloon time of 121 minutes. AUC indicates area
under the curve; ROC, Receiver operating characteristic.
DOI: 10.1161/JAHA.119.012429 Journal of the American Heart Association 6
CMR-Visualized Necrosis in STEMI Patients Greulich et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
ﬁnding that late PCI resulted in larger IS and smaller MSI,23,25
it is important to note that the IS is rather determined by the
IRA; for example, in the AAR of an occluded left circumﬂex
artery, IS may be rather small despite a high transmurality
index. Conversely, rapid recanalization of an occluded large
left anterior descending artery (with a large AAR) may reveal a
relatively large IS despite a relatively low transmurality index
and high MSI, respectively.
A meta-analysis of 2632 STEMI patients demonstrated that
IS measured by CMR or single-photon emission computed
tomography early after PCI was strongly associated with 1-
year hospitalization for heart failure and all-cause mortality,9
underscoring the high prognostic value of a distinct evaluation
of the IS in STEMI patients. In addition, LGE-CMR–derived MSI
is considered a more sensitive measure than IS alone because
it normalizes the IS to the AAR, which shows tremendous
interindividual variation.26
Beek et al demonstrated that the transmural extent is
relevant in predicting myocardial functional recovery: The
likelihood of complete functional recovery of segments
without LGE was 3.8, 11.1, and 50 times higher than that
of segments with 26% to 50%, 51% to 75%, and >75% LGE,
respectively (P<0.001).27 Other studies demonstrated a
signiﬁcant association with the extent of ischemic LGE and
mortality in patients with coronary arterial disease.7–9
The link between symptom-to-balloon time and the occur-
rence of transmural necrosis can be viewed in Figure 5. After
a 180-minute cutoff of symptom-to-balloon time, most
patients had irreversible transmural necrosis. Corroborating
this result, a pooled analysis revealed that IS was large when
the ﬁrst balloon inﬂation was performed >180 minutes from
symptom onset, with little impact of further delays beyond
180 minutes, suggesting a kind of plateau (or “ﬂat” part) of
the transmurality index and MSI curves.25 However, few
patients demonstrate substantial myocardial salvage in stages
at >180 minutes of symptom-to-balloon time, suggesting
some other potential mechanisms to salvage myocardium
(Figure 2).
Area at
risk
infarcted
area
A
D
B C
E F
Figure 4. Symptom-to-balloon time of 106 minutes: subendocardial necrosis. A 46-year-old man presenting with chest pain and ST-segment
elevation in the anterior leads. Coronary angiography revealed TIMI 0 occlusion of the LAD (A, arrow); primary PCI with stent implant was
performed, resulting in TIMI 3 ﬂow after PCI (D). Symptom-to-balloon time was 106 minutes. CMR revealed a preserved global left ventricular
ejection fraction (56%) with mild hypokinesia in the anteroseptal and apical wall. Late gadolinium enhancement CMR images revealed
subendocardial necrosis (arrows) in the anteroseptal wall (B, C, E) and the apex (E, F), consistent with the region supplied by the infarct-related
artery (LAD). CMR indicates cardiac magnetic resonance; LAD, left anterior descending; PCI, percutaneous coronary intervention; TIMI,
Thrombolysis in Myocardial Infarction.
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Successful recanalization of the IRA per se does not
guarantee the normalization of myocardial perfusion which is
impaired in 30% to 75% of patients due to MVO of various
extents.28 MVO refers to the inability to reperfuse the
intramyocardial microcirculation in an ischemic region despite
restoring ﬂow in the epicardial vessel and is accurately
displayed by LGE-CMR.11 These patients have a higher
prevalence of early postinfarct complications, adverse LV
remodeling, recurrent hospitalizations for heart failure, and
mortality.15,24,29–31 The high prevalence of MVO in our
population (64%) is similar to those in other reports showing
rates of MVO up to 60% in patients receiving primary PCI for
acute STEMI (Table 2).24,32 MVO was more common in
patients with longer symptom-to-balloon time (Figure 6),
which is consistent with previous data in STEMI patients.33,34
Aside from major logistic advancements (eg, prean-
nounced STEMI, direct handoff from ambulances to catheter-
ization laboratories), improved patient awareness may play a
crucial role in the reduction of the symptom-to-balloon time.
A prospective multicenter study of STEMI patients revealed
time intervals from onset of symptoms to ﬁrst medical
contact far beyond the symptom-to-balloon time that seemed
to be desirable in STEMI patients as suggested by this
study.35
Limitations
Although the wavefront concept of myocardial ischemia is
well accepted, there might be some lateral extent of MI,
leading to a certain inaccuracy in the deﬁnition of the AAR
(and its components). However, these potential inaccuracies
might be negligible.14
Myocardial blush grade did not differ signiﬁcantly between
patients with a symptom-to-balloon time >121 versus
≤121 minutes, but CMR-derived MVO was more common in
patients with a symptom-to-balloon time >121 minutes
(P=0.03). Symptom-to-balloon time does not necessarily
imply time to reperfusion because in some cases TIMI 3 ﬂow
cannot be achieved or, very rarely, the myocardial blush grade
is 0/1. Nevertheless, neither TIMI ﬂow after PCI nor
myocardial blush grade was signiﬁcantly different between
groups (Table 1).
T2-weighted images were not consistently performed.
Those images were used in some studies to delineate the
AAR.36,37 However, image quality is often impaired and prone
to artifacts, and T2-weighted images are problematic on many
levels.11, 38 Moreover, post-MI edema in patients is not stable
but follows a bimodal pattern that affects CMR estimates of
the AAR by T2-weighted images.39 Furthermore, Kim et al
clearly demonstrated that T2-weighted CMR does not depict
the AAR.14
Although coronary angiography is a commonly used
method for evaluation of collateral circulation, and visible
retrograde collateral ﬂow was systematically excluded from
the present study, smaller, invisible, but functionally
present and beneﬁcial collateral vessels may have been
missed.40,41
CMR mapping sequences were not performed. However,
despite the promising results of T1 mapping in STEMI for
measuring IS without the use of contrast agent, studies have
been small and from single centers.42,43 Larger multicenter
studies are required to investigate the clinical value of
mapping techniques before they can be more widely
adopted.
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Figure 5. Grade of transmurality at different symptom-to-balloon times. The left bar (cutoff: 90-minute symptom-to-balloon time)
demonstrates a signiﬁcant percentage of subendocardial MI at ≤90 minutes of symptom-to-balloon time. The middle bar (cutoff:
121 minutes) demonstrates a smaller but still substantial percentage of subendocardial MI ≤121 minutes. The right bar (cutoff:
180 minutes) shows further reduction in the percentage of subendocardial MI ≤180 minutes. MI indicates myocardial infarction.
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Conclusions
In MI not mitigated by either residual antegrade ﬂow through
incomplete coronary occlusion or visible retrograde collateral
ﬂow, immediate reperfusion is vital. A symptom-to-balloon time
>121 minutes causes a high grade of transmural necrosis. In
this pure STEMI population, time to reperfusion to salvage
myocardium was less than suggested by current guidelines.
Sources of Funding
This work was funded in part by the Robert Bosch Foundation:
KKF 13-2, KKF 15-5, and KKF 770. This project was supported
by the Deutsche Forschungsgemeinschaft (Klinische
Forschungsgruppe; KFO-274: “Platelets-Molecular Mecha-
nisms and Translational Implications”) and by the Deutsche
Forschungsgemeinschaft (German Research Foundation; no.
374031971–TRR 240).
Disclosures
None.
References
1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H,
Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A,
Lenzen MJ, Prescott E, Rofﬁ M, Valgimigli M, Varenhorst C, Vranckx P,
Widimsky P; ESC Scientiﬁc Document Group. 2017 ESC Guidelines for the
management of acute myocardial infarction in patients presenting with ST-
segment elevation: The Task Force for the management of acute myocardial
infarction in patients presenting with ST-segment elevation of the European
Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
2. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic
cell death. II. Transmural progression of necrosis within the framework of
ischemic bed size (myocardium at risk) and collateral ﬂow. Lab Invest.
1979;40:633–644.
A
D
B C
E F
Figure 6. Symptom-to-balloon time of 141 minutes: transmural necrosis and extensive MVO. A 48-year-old man presenting with chest pain
and ST-segment elevation in the anterior leads. Coronary angiography revealed TIMI 0 occlusion of the LAD (A); primary PCI with stent
implantation was performed, resulting in TIMI 3 ﬂow after PCI (D). Symptom-to-balloon time was 141 minutes. CMR revealed impaired left
ventricular ejection fraction (38%) with akinesia in the anteroseptal, septal, and apical wall. Late gadolinium enhancement CMR images
revealed extensive transmural necrosis with concomitant MVO (arrows) in the anteroseptal and septal wall (B, C, E) and the apex (E, F),
consistent with the region supplied by the infarct-related artery (large LAD). CMR indicates cardiac magnetic resonance; LAD, left anterior
descending; MVO, microvascular obstruction; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction.
DOI: 10.1161/JAHA.119.012429 Journal of the American Heart Association 9
CMR-Visualized Necrosis in STEMI Patients Greulich et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
3. Seiler C, Kirkeeide RL, Gould KL. Measurement from arteriograms of regional
myocardial bed size distal to any point in the coronary vascular tree for
assessing anatomic area at risk. J Am Coll Cardiol. 1993;21:783–797.
4. Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation
of primary percutaneous coronary intervention for acute myocardial
infarction: is the slope of the curve the shape of the future? JAMA.
2005;293:979–986.
5. Eitel I, Desch S, de Waha S, Fuernau G, Gutberlet M, Schuler G, Thiele H. Long-
term prognostic value of myocardial salvage assessed by cardiovascular
magnetic resonance in acute reperfused myocardial infarction. Heart.
2011;97:2038–2045.
6. Bodi V, Sanchis J, Nunez J, Mainar L, Lopez-Lereu MP, Monmeneu JV, Rumiz E,
Chaustre F, Trapero I, Husser O, Forteza MJ, Chorro FJ, Llacer A. Prognostic
value of a comprehensive cardiac magnetic resonance assessment soon after
a ﬁrst ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging.
2009;2:835–842.
7. Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ,
Boersma E, van der Wall EE, Fleck E, de Roos A, Nagel E, Bax JJ. Comparison
of myocardial infarct size assessed with contrast-enhanced magnetic
resonance imaging and left ventricular function and volumes to predict
mortality in patients with healed myocardial infarction. Am J Cardiol.
2007;100:930–936.
8. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee
VV, Flamm SD. Prognostic signiﬁcance of delayed-enhancement magnetic
resonance imaging: survival of 857 patients with and without left ventricular
dysfunction. Circulation. 2009;120:2069–2076.
9. Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A,
Eitel I, Granger CB, Jenkins PL, Nichols M, Ben-Yehuda O. Relationship
between infarct size and outcomes following primary PCI: patient-level analysis
from 10 randomized trials. J Am Coll Cardiol. 2016;67:1674–1683.
10. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ,
Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon
emission computed tomography (SPECT) perfusion imaging for detection of
subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–
379.
11. Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular
magnetic resonance in acute ST-segment-elevation myocardial infarction:
recent advances, controversies, and future directions. Circulation.
2018;137:1949–1964.
12. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich
MG, Kim RJ, von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, Plein S,
Nagel E. Standardized image interpretation and post processing in cardiovas-
cular magnetic resonance: Society for Cardiovascular Magnetic Resonance
(SCMR) board of trustees task force on standardized post processing. J
Cardiovasc Magn Reson. 2013;15:35.
13. Ortiz-Perez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, Davidson CJ,
Bonow RO, Wu E. Angiographic estimates of myocardium at risk during acute
myocardial infarction: validation study using cardiac magnetic resonance
imaging. Eur Heart J. 2007;28:1750–1758.
14. Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG,
Wendell DC, Bhatti L, Spatz DM, Parker MA, Jenista ER, Klem I, Crowley AL,
Chen EL, Judd RM, Kim RJ. Relationship of T2-weighted MRI myocardial
hyperintensity and the ischemic area-at-risk. Circ Res. 2015;117:254–265.
15. de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda
O, Jenkins P, Thiele H, Stone GW. Relationship between microvascular
obstruction and adverse events following primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction: an individual
patient data pooled analysis from seven randomized trials. Eur Heart J.
2017;38:3502–3510.
16. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint
ESC/ACCF/AHA/WHF Task Force for the Universal Deﬁnition of Myocardial
Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod
H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby
LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP,
Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW,
Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker
RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-
Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN,
Vasilieva EJ, Mendis S. Third universal deﬁnition of myocardial infarction.
Circulation. 2012;126:2020–2035.
17. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM.
Reproducibility of chronic infarct size measurement by contrast-enhanced
magnetic resonance imaging. Circulation. 2002;106:2322–2327.
18. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP,
Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to
irreversible injury, infarct age, and contractile function. Circulation.
1999;100:1992–2002.
19. Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC, Lima JA.
Quantiﬁcation and time course of microvascular obstruction by contrast-
enhanced echocardiography and magnetic resonance imaging following acute
myocardial infarction and reperfusion. J Am Coll Cardiol. 1998;32:1756–1764.
20. Yokota H, Heidary S, Katikireddy CK, Nguyen P, Pauly JM, McConnell MV, Yang
PC. Quantitative characterization of myocardial infarction by cardiovascular
magnetic resonance predicts future cardiovascular events in patients with
ischemic cardiomyopathy. J Cardiovasc Magn Reson. 2008;10:17.
21. Khera S, Kolte D, Gupta T, Subramanian KS, Khanna N, Aronow WS, Ahn C,
Timmermans RJ, Cooper HA, Fonarow GC, Frishman WH, Panza JA, Bhatt DL.
Temporal trends and sex differences in revascularization and outcomes of ST-
segment elevation myocardial infarction in younger adults in the United
States. J Am Coll Cardiol. 2015;66:1961–1972.
22. Kosmidou I, Redfors B, Selker HP, Thiele H, Patel MR, Udelson JE, Magnus
Ohman E, Eitel I, Granger CB, Maehara A, Kirtane A, Genereux P, Jenkins PL,
Ben-Yehuda O, Mintz GS, Stone GW. Infarct size, left ventricular function, and
prognosis in women compared to men after primary percutaneous coronary
intervention in ST-segment elevation myocardial infarction: results from an
individual patient-level pooled analysis of 10 randomized trials. Eur Heart J.
2017;38:1656–1663.
23. Stiermaier T, Eitel I, de Waha S, P€oss J, Fuernau G, Thiele H, Desch S.
Myocardial salvage after primary percutaneous coronary intervention in
patients with ST-elevation myocardial infarction presenting early versus late
after symptom onset. Int J Cardiovasc Imaging. 2017;33:1571–1579.
24. van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y,
Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P,
Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ. Prognostic value of
microvascular obstruction and infarct size, as measured by CMR in STEMI
patients. JACC Cardiovasc Imaging. 2014;7:930–939.
25. Stone GW, Dixon SR, Grines CL, Cox DA, Webb JG, Brodie BR, Grifﬁn JJ, Martin
JL, Fahy M, Mehran R, Miller TD, Gibbons RJ, O’Neill WW. Predictors of infarct
size after primary coronary angioplasty in acute myocardial infarction from
pooled analysis from four contemporary trials. Am J Cardiol. 2007;100:1370–
1375.
26. Bøtker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage.
Cardiovasc Res. 2012;94:266–275.
27. Beek AM, K€uhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG,
Visser CA, van Rossum AC. Delayed contrast-enhanced magnetic resonance
imaging for the prediction of regional functional improvement after acute
myocardial infarction. J Am Coll Cardiol. 2003;42:895–901.
28. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reﬂow in humans. J Am
Coll Cardiol. 2009;54:281–292.
29. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP,
Blumenthal RS, Lima JA. Prognostic signiﬁcance of microvascular obstruction
by magnetic resonance imaging in patients with acute myocardial infarction.
Circulation. 97:765–772.
30. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G,
Antoniucci D. Impact of microvascular dysfunction on left ventricular
remodeling and long-term clinical outcome after primary coronary angioplasty
for acute myocardial infarction. Circulation. 2004;109:1121–1126.
31. de Waha S, Desch S, Eitel I, Fuernau G, Zachrau J, Leuschner A, Gutberlet M,
Schuler G, Thiele H. Impact of early vs. late microvascular obstruction
assessed by magnetic resonance imaging on long-term outcome after ST-
elevation myocardial infarction: a comparison with traditional prognostic
markers. Eur Heart J. 2010;31:2660–2668.
32. Feistritzer HJ, Reinstadler SJ, Klug G, Reindl M, W€ohrer S, Brenner C, Mayr
A, Mair J, Metzler B. Multimarker approach for the prediction of
microvascular obstruction after acute ST-segment elevation myocardial
infarction: a prospective, observational study. BMC Cardiovasc Disord.
2016;16:239.
33. Tarantini G, Cacciavillani L, Corbetti F, Ramondo A, Marra MP, Bacchiega E,
Napodano M, Bilato C, Razzolini R, Iliceto S. Duration of ischemia is a major
determinant of transmurality and severe microvascular obstruction after
primary angioplasty: a study performed with contrast-enhanced magnetic
resonance. J Am Coll Cardiol. 2005;46:1229–1235.
34. Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA,
Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J, Agati L.
Impact of primary coronary angioplasty delay on myocardial salvage, infarct
size, and microvascular damage in patients with ST-segment elevation
myocardial infarction: insight from cardiovascular magnetic resonance. J Am
Coll Cardiol. 2009;54:2145–2153.
35. Scholz KH, Maier SK, Jung J, Fleischmann C, Werner GS, Olbrich HG,
Ahlersmann D, Keating FK, Jacobshagen C, Moehlis H, Hilgers R, Maier LS.
Reduction in treatment times through formalized data feedback: results from a
prospective multicenter study of ST-segment elevation myocardial infarction.
JACC Cardiovasc Interv. 2012;5:848–857.
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
DOI: 10.1161/JAHA.119.012429 Journal of the American Heart Association 10
CMR-Visualized Necrosis in STEMI Patients Greulich et al
36. Berry C, Kellman P, Mancini C, Chen MY, Bandettini WP, Lowrey T, Hsu LY,
Aletras AH, Arai AE. Magnetic resonance imaging delineates the ischemic area
at risk and myocardial salvage in patients with acute myocardial infarction.
Circ Cardiovasc Imaging. 2010;3:527–535.
37. Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Kastrati A, Martinoff S,
Sch€omig A, Ibrahim T. The assessment of area at risk and myocardial salvage
after coronary revascularization in acute myocardial infarction: comparison
between CMR and SPECT. JACC Cardiovasc Imaging. 2013;6:358–369.
38. Croisille P, Kim HW, Kim RJ. Controversies in cardiovascular MR imaging: T2-
weighted imaging should not be used to delineate the area at risk in ischemic
myocardial injury. Radiology. 2012;265:12–22.
39. Fernandez-Jimenez R, Barreiro-Perez M, Martin-Garcıa A, Sanchez-Gonzalez J,
Ag€uero J, Galan-Arriola C, Garcıa-Prieto J, Dıaz-Pelaez E, Vara P, Martinez I,
Zamarro I, Garde B, Sanz J, Fuster V, Sanchez PL, Ibanez B. Dynamic
edematous response of the human heart to myocardial infarction: implications
for assessing myocardial area at risk and salvage. Circulation. 2017;136:
1288–1300.
40. Seiler C, Engler R, Berner L, Stoller M, Meier P, Steck H, Traupe T. Prognostic
relevance of coronary collateral function: confounded or causal relationship?
Heart. 2013;99:1408–1414.
41. Wustmann K, Zbinden S, Windecker S, Meier B, Seiler C. Is there functional
collateral ﬂow during vascular occlusion in angiographically normal coronary
arteries? Circulation. 2003;107:2213–2220.
42. Bulluck H, Hammond-Haley M, Fontana M, Knight DS, Sirker A, Herrey AS,
Manisty C, Kellman P, Moon JC, Hausenloy DJ. Quantiﬁcation of both the
area-at-risk and acute myocardial infarct size in ST-segment elevation
myocardial infarction using T1-mapping. J Cardiovasc Magn Reson.
2017;19:57.
43. Liu D, Borlotti A, Viliani D, Jerosch-Herold M, Alkhalil M, De Maria GL, Fahrni G,
Dawkins S, Wijesurendra R, Francis J, Ferreira V, Piechnik S, Robson MD,
Banning A, Choudhury R, Neubauer S, Channon K, Kharbanda R, Dall’Armellina
E. CMR native T1 mapping allows differentiation of reversible versus
irreversible myocardial damage in ST-segment-elevation myocardial infarction:
an OxAMI Study (Oxford Acute Myocardial Infarction). Circ Cardiovasc Imaging.
2017;10:e005986.
DOI: 10.1161/JAHA.119.012429 Journal of the American Heart Association 11
CMR-Visualized Necrosis in STEMI Patients Greulich et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
